Christopher Coira
About Christopher Coira
Christopher Coira is the Associate Director and Risk Management Lead at Bristol-Myers Squibb, with over a decade of experience in clinical project management and risk management within the pharmaceutical industry.
Title
Christopher Coira holds the position of Associate Director, Risk Management Lead at Bristol-Myers Squibb. His role involves leading risk management strategies and solutions to ensure compliance and mitigate risks within clinical operations.
Company
Christopher Coira is currently associated with Bristol-Myers Squibb, a global biopharmaceutical company. At Bristol-Myers Squibb, his contributions span multiple roles including, but not limited to, Associate Director, Risk Management Lead, Senior Clinical Project Manager, and Protocol Manager.
Education and Expertise
Christopher Coira earned his Master of Business Administration (MBA) from the University of Massachusetts, Amherst, with a focus on Business Administration and Management, between 2014 and 2016. He also holds a Bachelor of Science (B.S.) degree in Business Administration with a concentration in Marketing from Towson University, completed between 2007 and 2011. His academic foundation supports his extensive expertise in clinical project management and risk management within the pharmaceutical industry.
Professional Background
Christopher Coira began his career at BioClinica, holding numerous roles including Project Coordinator and Clinical Project Manager, from 2011 to 2016. He later served as Protocol Manager at DOCS before continuing at Bristol-Myers Squibb. At Bristol-Myers Squibb, he undertook the responsibilities of a Senior Clinical Project Manager and Protocol Manager before stepping into his current leadership role. His professional journey reflects significant experience and contributions across various projects and operational facets of clinical management.
Achievements
Christopher Coira is recognized for his problem-solving and analytical skills, having developed effective solutions for complex issues in clinical operations. His strong communication abilities have earned him the trust of both clients and internal stakeholders. With a proven track record of working in high-performance teams, Christopher has established himself as a valued partner within the pharmaceutical industry.